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Background: In accordance with the CDC’s 2010 Guidelines for Prevention of
Perinatal Group B Streptococcal Disease, 100% of all well-appearing infants admitted to
our Level III NICU admitted for maternal chorioamnionitis have undergone a limited
early-onset sepsis (EOS) evaluation and started on IV antibiotics for a minimum of 48
hours. Studies have shown potential negative consequences of early antibiotic exposure,
as well as separation of the mother-baby dyad. Subsequently, tools such as the Kaiser
Permanente EOS Calculator have been developed to aid in the clinical evaluation of this
patient population. As an institution involved in the Baby Friendly Initiative, it was
prudent that we investigate the benefits of a modified sepsis protocol.
Objective: Decrease the routine use of antibiotics in well-appearing infants > 34 weeks
gestation exposed to chorioamnionitis by 40%.
Design/Methods: The project was implemented in three PDSA cycles.
Cycle 1: Reviewed current practices, performed literature reviews, and developed a
multidisciplinary chorioamnionitis taskforce. Members of the taskforce developed an
updated sepsis protocol, provided formal staff education, and created a tracking form for
which baseline data was collected on all infants whose mothers were diagnosed with
chorioamnionitis.
Cycle 2: Implementation of the updated sepsis protocol with patient tracking.
Cycle 3: Re-education of all staff on the EOS calculator and updated protocol.
Results: Three PDSA cycles were completed over a 6-month period (Figure 1).
Cycle 1: Thirteen infants were included and 100% were started on antibiotics. 3/13
received a 7-day antibiotic course for presumed clinical sepsis.
Cycle 2: Seven infants were included in this cycle. Only 2/7 infants were started on
antibiotics, a 70% reduction in antibiotic use.
Cycle 3: Following re-education, four patients were included in this cycle. There was
100% use of the EOS calculator and 50% reduction in antibiotic use (Figure 2).
Conclusions: We exceeded our goal of 40%, with a 70% reduction in antibiotic use for
infants exposed to maternal chorioamnionitis. Implementation of the EOS calculator has
reduced antibiotic exposure and number of laboratory evaluation at our busy, high
volume delivery hospital. Our planned next steps are to include the evaluation of workflow for all involved in care of these infants and improve education for the family
members.

Figure 1. Run Chart

Figure 2. Process and Balancing Measures

